Sector: Pharmaceuticals & Biotechnology

Small Cap

Vivimed Labs Share Price

Q: What is the current share price of Vivimed Labs Ltd.?

As of 9 June 2026 at 10:14 AM, the share price for Vivimed Labs Ltd. is ₹ 6.16 on the NSE and ₹ 6.26 on the BSE. (Note: Prices are dynamic and update frequently during market hours).

Q: What is the Market Capitalization of Vivimed Labs Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 9 June 2026, the market cap for Vivimed Labs Ltd. is approximately ₹ 51 Cr.

Q: What are the PE and PB ratios for Vivimed Labs Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Vivimed Labs Ltd. is -1.5, and the Price-to-Book (PB) ratio is -0.7.

Q: What is the 52-Week High and Low for Vivimed Labs Ltd.?

Over the past 52 weeks, the highest price reached by Vivimed Labs Ltd. shares was ₹ 29.4, and the lowest price was ₹ 5.15.

Q: Who are the major shareholders of Vivimed Labs Ltd.?

Significant shareholdings in Vivimed Labs Ltd. typically include entities such as: Public Promoter FII Other Institutions (Note: Shareholding patterns can change; this represents major holders based on recent filings).

Q: Who are the peers of Vivimed Labs Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Vivimed Labs Ltd. is often compared with other major players such as Bio Medica Laboratories, Goldline Pharmaceutical, Sai Parenterals, Speciality Medicines, Accretion Nutraveda and Rekvina Laboratories for analysis and benchmarking.

Q: What is the latest dividend information for Vivimed Labs Ltd.?

Vivimed Labs Ltd. last declared a FINAL dividend of ₹ 0.4 per share for the financial period ending 2018. The record date was set as 2018-09-19, and the payment was/is scheduled around 2018-09-19. For the most current dividend announcements, refer to official company filings.

Vivimed Labs Ltd.

₹6.16

-0.07(-1.12%)

Trade Now

9th Jun 2026 | 3:26 PM

NSE : VIVIMEDLAB

Open Free Demat Account

Vivimed Labs Performance

Price Movement

₹6.16

₹6.13

₹6.35

↘ Today's Low↗ Today's High

1 Year Performance

₹6.16

₹5.15

₹29.40

↘ 52 Week Low↗ 52 Week High

Markets Today

High₹6.35

Low₹6.13

Open at₹6.23

Prev Close₹6.23

Volumes80.81 K

Avg Price₹6.24

Lower Circuit₹5.92

Upper Circuit₹6.54

Historical Performance

3M High₹8.10

3M Low₹5.15

1 Yr High₹29.40

1 Yr Low₹5.15

3 Yr High₹29.40

3 Yr Low₹4.85

5 Yr High₹30.20

5 Yr Low₹4.85

Summary

As of 09-06-2026 23:24, Vivimed Labs Ltd. share price today is ₹0, with a change of ₹-6.23 (-100.00%) from the previous close of ₹6.23. The stock opened at ₹6.23 and traded between ₹6.13 and ₹6.35, with a total traded volume of 80812 shares. The company has a market capitalization of ₹51 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹29.4 and ₹5.15, respectively.

Vivimed Labs Ltd. valuation metrics include a P/E ratio of -1.5, EPS of ₹-3.85, and book value of ₹-0.70. Vivimed Labs Ltd. has reported revenue of ₹83.6 Cr and net profit of ₹-34.95 Cr.

Vivimed Labs Ltd. technical indicators include Day RSI at 40.46, Day MFI at 54.34, Day ADX at 16.63. Additional indicators include Commodity Channel Index (CCI) at -166.1 and Williams %R at -81.71. Momentum indicators show Day MACD at -0.11, Day MACD Signal Line at -0.1, DayATR at 0.41. Rate of Change indicators for Vivimed Labs Ltd. include ROC125 at 2.98 and ROC21 at -10.62.

Exponential moving averages include EMA5 at ₹6.4, EMA10 at ₹6.4, EMA12 at ₹6.4, EMA20 at ₹6.5, EMA26 at ₹6.6, EMA50 at ₹6.8, EMA100 at ₹7.4, EMA200 at ₹8.8. Simple moving averages include SMA5 at ₹6.4, SMA10 at ₹6.4, SMA20 at ₹6.5, SMA30 at ₹6.6, SMA50 at ₹6.6, SMA100 at ₹7.2, SMA150 at ₹8.4, SMA200 at ₹8.9.

Support levels for Vivimed Labs are placed at First Support ₹6.03, Second Support ₹5.82, Third Support ₹5.57. Resistance levels are seen at First Resistance ₹6.49, Second Resistance ₹6.74, Third Resistance ₹6.95. Vivimed Labs Ltd. shareholding pattern shows promoter holding at 7.57%, FII holding at 1.64%, DII holding at 0%, public holding at 90.66%.

Vivimed Labs Fundamentals

Market Cap

Low in industry

51 Cr.

PE Ratio (TTM)

Negative PE TTM

-1.50

Dividend Yield

Net Profit TTM

66% decr over last year

-34.95

Net Profit Growth

66% decr over last year

-34.95

PEG Ratio

Below industry Median

ROE

Operating Revenue TTM

83.60

Operating Revenue Growth

35% decr over last year

Book Value

Negative Price to Book

-0.70

MFI

MFI is mid-range

54.34

RSI

RSI is mid-range

40.46

EPS (TTM)

-3.85

Debt to Equity

-5.14

Face Value

Operating Profit Margin Qtr.

-10.82

Operating Profit Qtr.

-10.92

Net Profit Qtr.

-16.55

Operating Revenue Qtr.

15.99

PB Ratio

-0.70

Vivimed Labs Financials

*All values are in Rs. Cr

Loading chart...

Indicator	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024
Total Revenue	11.63	18.66	17.94	22.58	34.23
Operating Expense	22.85	19.98	18.48	25.06	34.41
Operating Profit	-11.22	-1.32	-0.54	-2.48	-0.18
Depreciation	4.40	4.68	4.80	4.61	6.37
Interest	0.94	1.60	0.52	1.48	0.43
Tax	0	0	0	0	0
Net Profit	-16.57	-7.44	-5.50	-4.42	-6.97

Vivimed Labs Technicals

Vivimed Labs Ltd. EMA & SMA

₹6.16

-0.07 (-1.12%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹6.4

Day EMA10 ₹6.4

Day EMA12 ₹6.4

Day EMA20 ₹6.5

Day EMA26 ₹6.6

Day EMA50 ₹6.8

Day EMA100 ₹7.4

Day EMA200 ₹8.8

Vivimed Labs Support and Resistance

Resistance

First Resistance₹6.49

Second Resistance₹6.74

Third Resistance₹6.95

Support

First Support₹6.03

Second Support₹5.82

Third Support₹5.57

Technical Indicators

Day RSI40.46

Day MFI54.34

Day ADX16.63

Day Commodity Channel Index-166.10

William-81.71

Day MACD-0.11

Day MACD Signal Line-0.10

Day ATR0.41

Day ROC1252.98

Day ROC21-10.62

Vivimed Labs Shareholding Pattern

Held By	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Promoter	20.9	20.9	7.8	7.8	7.8	7.6
FII	1.6	1.6	1.6	1.6	1.6	1.6
DII	0.2	0.2	0.2	0.2	0.2	0.2
Public	77.3	77.3	90.5	90.5	90.5	90.7

Vivimed Labs Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	1.1 L	1.1 L	100.00%
Week	85.57 K	85.57 K	100.00%
1 Month	94.52 K	94.52 K	100.00%
6 Month	2.41 L	3.2 L	75.49%

Vivimed Labs SWOT Analysis

Strengths8

Weakness20

Opportunity0

Threats0

Relative Outperformance versus Industry over 1 Year

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

Effectively using its capital to generate profit - RoCE improving in last 2 years

Efficient in managing Assets to generate Profits - ROA improving since last 2 year

Company able to generate Net Cash - Improving Net Cash Flow for last 2 years

Annual Net Profits improving for last 2 years

Stock with Low PE (PE < = 10)

Vivimed Labs Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Instrument Type
19 Sep, 2018	0.4	FINAL	Equity Share
21 Sep, 2017	0.4	FINAL	Equity Share
24 Sep, 2014	3	FINAL	Equity Share
24 Sep, 2013	3	FINAL	Equity Share
21 Sep, 2012	3	FINAL	Equity Share
26 Sep, 2011	2	FINAL	Equity Share
09 Sep, 2010	1.5	FINAL	Equity Share
24 Sep, 2009	1.5	FINAL	Equity Share
22 Sep, 2008	1	FINAL	Equity Share

Vivimed Labs Stock Comparison

Financials	Sai Parenterals Ltd.	Amanta Healthcare Ltd.	Anlon Healthcare Ltd.	Amrutanjan Health Care Ltd.	Senores Pharmaceuticals Ltd.
Price (₹)	₹558.75	₹136.48	₹15.10	₹563.90	₹1,095
% Change	1.42%	4.30%	7.40%	1.25%	8.74%
Revenue TTM (₹ Cr)	-	₹287.68	₹176.50	₹502.55	₹649.50
Net Profit TTM (₹ Cr)	-	₹14.88	₹27.81	₹57.92	₹115.38
PE TTM	-	35.40	28.90	28.00	43.70
1 Year Return	42.87	7.51	66.37	-21.47	105.39
ROCE	3.56	-	17.36	23.87	15.60

Similar Stocks

INNOVACAP

Innova Captab Ltd.

₹ 917.10

+5.41%

VALIANTLAB

Valiant Laboratories Ltd.

₹ 73.00

-1.27%

SIGACHI

Sigachi Industries Ltd.

₹ 21.27

+0.76%

WINDLAS

Windlas Biotech Ltd.

₹ 830.00

+1.94%

VINEETLAB

Vineet Laboratories Ltd.

₹ 33.50

+0.33%

SOLARA

Solara Active Pharma Sciences Ltd.

₹ 574.00

+9.35%

ZIMLAB

Zim Laboratories Ltd.

₹ 113.05

+5.00%

MEDICO

Medico Remedies Ltd.

₹ 42.82

-1.95%

DCAL

Dishman Carbogen Amcis Ltd.

₹ 189.00

+2.51%

LASA

Lasa Supergenerics Ltd.

₹ 7.61

-0.65%

ADVENZYMES

Advanced Enzyme Technologies Ltd.

₹ 373.30

+0.35%

BAJAJHCARE

Bajaj Healthcare Ltd.

₹ 290.05

-0.17%

ORTINGLOBE

Ortin Global Ltd.

₹ 17.93

-9.99%

BROOKS

Brooks Laboratories Ltd.

₹ 69.00

+3.51%

RPGLIFE

RPG Life Sciences Ltd.

₹ 2110.10

+1.01%

BAFNAPH

Bafna Pharmaceuticals Ltd.

₹ 174.58

-10.00%

ALPA

Alpa Laboratories Ltd.

₹ 69.80

+2.29%

SMSPHARMA

SMS Pharmaceuticals Ltd.

₹ 380.00

+3.04%

NECLIFE

Nectar Lifesciences Ltd.

₹ 11.60

-0.34%

MANGALAM

Mangalam Drugs and Organics Ltd.

₹ 28.40

-0.18%

INDOCO

Indoco Remedies Ltd.

₹ 207.00

+3.74%

INDSWFTLAB

Ind-Swift Laboratories Ltd.

₹ 163.70

+4.44%

LINCOLN

Lincoln Pharmaceuticals Ltd.

₹ 635.50

+2.53%

PANACEABIO

Panacea Biotec Ltd.

₹ 612.00

+10.69%

FAQ's on VIVIMEDLAB

What is the current share price of Vivimed Labs Ltd.?

As of 9 June 2026 at 10:14 AM, the share price for Vivimed Labs Ltd. is ₹ 6.16 on the NSE and ₹ 6.26 on the BSE. (Note: Prices are dynamic and update frequently during market hours).

What is the Market Capitalization of Vivimed Labs Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 9 June 2026, the market cap for Vivimed Labs Ltd. is approximately ₹ 51 Cr.

What are the PE and PB ratios for Vivimed Labs Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Vivimed Labs Ltd. is -1.5, and the Price-to-Book (PB) ratio is -0.7.

What is the 52-Week High and Low for Vivimed Labs Ltd.?

Over the past 52 weeks, the highest price reached by Vivimed Labs Ltd. shares was ₹ 29.4, and the lowest price was ₹ 5.15.

Who are the major shareholders of Vivimed Labs Ltd.?

Significant shareholdings in Vivimed Labs Ltd. typically include entities such as:

Public
Promoter
FII
Other Institutions

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of Vivimed Labs Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Vivimed Labs Ltd. is often compared with other major players such as Bio Medica Laboratories, Goldline Pharmaceutical, Sai Parenterals, Speciality Medicines, Accretion Nutraveda and Rekvina Laboratories for analysis and benchmarking.

What is the latest dividend information for Vivimed Labs Ltd.?

Vivimed Labs Ltd. last declared a FINAL dividend of ₹ 0.4 per share for the financial period ending 2018. The record date was set as 2018-09-19, and the payment was/is scheduled around 2018-09-19. For the most current dividend announcements, refer to official company filings.

Invest Anytime, Anywhere

By signing up I certify terms, conditions & privacy policy